Rankings
▼
Calendar
BVS Q2 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
Q2 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$137M
-2.3% YoY
Gross Profit
$89M
65.0% margin
Operating Income
$7M
4.9% margin
Net Income
-$4M
-2.7% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+15.1%
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$9M
Stock-Based Comp.
-$3M
Balance Sheet
Total Assets
$837M
Total Liabilities
$604M
Stockholders' Equity
$183M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$137M
$140M
-2.3%
Gross Profit
$89M
$97M
-7.8%
Operating Income
$7M
-$3M
+304.1%
Net Income
-$4M
-$7M
+49.2%
Geographic Segments
UNITED STATES
$33M
86%
Non-US
$5M
14%
← FY 2023
All Quarters
Q3 2023 →